On June 13, 2024, the Supreme Court of the United States unanimously rejected a challenge to the U.S. Food & Drug Administration (“FDA”) approval and regulation of mifepristone (brand name “Mifeprix”), a drug used in medically induced abortions. In a 9-0 decision delivered by Justice Brett Kavanaugh, the Supreme Court held that the plaintiffs,... READ MORE
U.S. Supreme Court Issues Ruling Rejecting Challenge to Mifepristone Access
Posted on June 18, 2024 in Health Law News
Published by: Hall Render
